Expanded Access for CC-10004
- Conditions
- Bechet's Disease
- Registration Number
- NCT03740516
- Lead Sponsor
- Amgen
- Brief Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Celgene
🇺🇸Summit, New Jersey, United States